BHVN

Biohaven Ltd.CIK 1935979 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for BHVN PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for BHVN

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Gentile Kimberly	VP of Operations	143	$0	$6.10M	2026-09-15
Antonijevic Irina	Director	11	$0	$459.7K	2026-04-28
Mehta Kishan	Director	32	$0	$0	2026-04-28
Heffernan Michael Thomas	Director	28	$0	$0	2026-04-28
Bailey Gregory	Director	96	$18.02M	$41.14M	2026-04-28
HUGIN ROBERT J	Director	28	$0	$0	2026-04-28
GREGORY JULIA P	Director	38	$100.0K	$2.68M	2026-04-28
CHILDS JOHN W	Director, 10% Owner	88	$150.68M	$11.07M	2026-04-28
Buten Matthew	Officer	32	$2.00M	$0	2026-02-27
Clark George C.	VP, Chief Accounting Officer	55	$144.8K	$1.93M	2026-02-27
Car Bruce	Chief Scientific Officer	13	$1.01M	$0	2026-02-27
Coric Vlad	Chief Executive Officer	176	$37.69M	$11.17M	2026-02-27
Stock Elyse	Chief Medical Officer	86	$0	$6.27M	2022-10-03
Conway Charles	Chief Scientific Officer	45	$68.0K	$0	2022-10-03
Engelhart James	Strategic Advisor	80	$150.1K	$9.86M	2022-10-03
Tilton John	Chief Commercial Officer	59	$0	$5.28M	2022-10-03
Biohaven Pharmaceutical Holding Co Ltd.	10% Owner	2	$0	$0	2022-10-03
JONES WILLIAM A JR	CCO-Migraine & Common Disease	42	$0	$2.29M	2022-10-03
Doogan Declan	Director	91	$0	$64.21M	2021-11-29
Berman Robert	Special Projects & Med Ovrsght	96	$106.6K	$33.34M	2020-07-08
AGUIAR ERIC	Director	41	$0	$3.10M	2020-01-22
Repella Robert	Director	2	$0	$0	2019-05-21
Cha Albert	Director	5	$7.99M	$0	2018-05-01
PORTAGE BIOTECH INC.	Other	10	$0	$8.06B	2018-01-23

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Gentile Kimberly	SVP, Clinical Operations	A Award deriv	2026-09-15	2026-09-17	1,000	—	$0	1,000	SEC↗
Gentile Kimberly	SVP, Clinical Operations	A Award deriv	2026-09-15	2026-09-17	1,000	—	$0	1,000	SEC↗
GREGORY JULIA P	Director	A Award deriv	2026-04-28	2026-04-30	68,693	—	$0	68,693	SEC↗
HUGIN ROBERT J	Director	A Award deriv	2026-04-28	2026-04-30	68,693	—	$0	68,693	SEC↗
CHILDS JOHN W	Director	A Award deriv	2026-04-28	2026-04-30	68,693	—	$0	68,693	SEC↗
Antonijevic Irina	Director	A Award deriv	2026-04-28	2026-04-30	68,693	—	$0	68,693	SEC↗
Heffernan Michael Thomas	Director	A Award deriv	2026-04-28	2026-04-30	68,693	—	$0	68,693	SEC↗
Bailey Gregory	Director	A Award deriv	2026-04-28	2026-04-30	68,693	—	$0	68,693	SEC↗
Mehta Kishan	Director	A Award deriv	2026-04-28	2026-04-30	68,693	—	$0	68,693	SEC↗
Mehta Kishan	Director	G Gift	2026-03-17	2026-03-19	17,342	—	$0	17,342	SEC↗
Mehta Kishan	Director	G Gift	2026-03-17	2026-03-19	17,342	—	$0	5,320	SEC↗
Coric Vlad	Chief Executive Officer	A Award deriv	2026-02-27	2026-03-03	550,000	—	$0	550,000	SEC↗
Car Bruce	Chief Scientific Officer	A Award deriv	2026-02-27	2026-03-03	175,000	—	$0	175,000	SEC↗
Clark George C.	VP, Chief Accounting Officer	A Award deriv	2026-02-27	2026-03-03	50,000	—	$0	50,000	SEC↗
Gentile Kimberly	SVP, Clinical Operations	A Award deriv	2026-02-27	2026-03-03	175,000	—	$0	175,000	SEC↗
Buten Matthew	Chief Financial Officer	A Award deriv	2026-02-27	2026-03-03	175,000	—	$0	175,000	SEC↗
Clark George C.	VP, Chief Accounting Officer	M Exercise deriv	2026-01-05	2026-01-07	2,500	—	$0	5,000	SEC↗
Car Bruce	Chief Scientific Officer	M Exercise deriv	2026-01-05	2026-01-07	4,750	—	$0	9,500	SEC↗
Coric Vlad	Chief Executive Officer	M Exercise deriv	2026-01-05	2026-01-07	14,250	—	$0	28,500	SEC↗
Buten Matthew	Chief Financial Officer	M Exercise deriv	2026-01-05	2026-01-07	4,250	—	$0	8,500	SEC↗
Gentile Kimberly	SVP, Clinical Operations	M Exercise deriv	2026-01-05	2026-01-07	3,750	—	$0	7,500	SEC↗
Clark George C.	VP, Chief Accounting Officer	F Tax w/h	2026-01-05	2026-01-07	1,117	$9.93	$11.1K	66,978	SEC↗
Clark George C.	VP, Chief Accounting Officer	M Exercise	2026-01-05	2026-01-07	2,500	—	$0	68,095	SEC↗
Car Bruce	Chief Scientific Officer	M Exercise	2026-01-05	2026-01-07	4,750	—	$0	10,096	SEC↗
Car Bruce	Chief Scientific Officer	F Tax w/h	2026-01-05	2026-01-07	2,381	$9.93	$23.6K	7,715	SEC↗
Coric Vlad	Chief Executive Officer	M Exercise	2026-01-05	2026-01-07	14,250	—	$0	1,811,398	SEC↗
Coric Vlad	Chief Executive Officer	F Tax w/h	2026-01-05	2026-01-07	7,430	$9.93	$73.8K	1,803,968	SEC↗
Buten Matthew	Chief Financial Officer	M Exercise	2026-01-05	2026-01-07	4,250	—	$0	198,246	SEC↗
Buten Matthew	Chief Financial Officer	F Tax w/h	2026-01-05	2026-01-07	2,594	$9.93	$25.8K	195,652	SEC↗
Gentile Kimberly	SVP, Clinical Operations	M Exercise	2026-01-05	2026-01-07	3,750	—	$0	101,513	SEC↗
Gentile Kimberly	SVP, Clinical Operations	F Tax w/h	2026-01-05	2026-01-07	1,956	$9.93	$19.4K	99,557	SEC↗
Clark George C.	VP, Chief Accounting Officer	P Buy	2025-11-17	2025-11-18	17,000	$8.52	$144.8K	20,000	SEC↗
Coric Vlad	Chief Executive Officer	P Buy	2025-11-13	2025-11-17	333,333	$7.50	$2.50M	1,195,275	SEC↗
Coric Vlad	Chief Executive Officer	P Buy	2025-11-13	2025-11-17	333,333	$7.50	$2.50M	740,546	SEC↗
CHILDS JOHN W	Director	P Buy	2025-11-13	2025-11-17	3,333,333	$7.50	$25.00M	5,653,904	SEC↗
Bailey Gregory	Director	P Buy	2025-11-13	2025-11-17	400,000	$7.50	$3.00M	2,020,071	SEC↗
HUGIN ROBERT J	Director	A Award deriv	2025-05-05	2025-05-07	31,716	—	$0	31,716	SEC↗
CHILDS JOHN W	Director	A Award deriv	2025-05-05	2025-05-07	31,716	—	$0	31,716	SEC↗
GREGORY JULIA P	Director	A Award deriv	2025-05-05	2025-05-07	31,716	—	$0	31,716	SEC↗
Mehta Kishan	Director	A Award deriv	2025-05-05	2025-05-07	31,716	—	$0	31,716	SEC↗
Bailey Gregory	Director	A Award deriv	2025-05-05	2025-05-07	31,716	—	$0	31,716	SEC↗
Heffernan Michael Thomas	Director	A Award deriv	2025-05-05	2025-05-07	31,716	—	$0	31,716	SEC↗
Antonijevic Irina	Director	A Award deriv	2025-05-05	2025-05-07	31,716	—	$0	31,716	SEC↗
CHILDS JOHN W	Director	P Buy	2025-03-04	2026-03-09	28,400	$30.43	$864.2K	2,323,971	SEC↗
CHILDS JOHN W	Director	P Buy	2025-03-04	2025-03-05	25,000	$30.39	$759.8K	2,320,571	SEC↗
CHILDS JOHN W	Director	P Buy	2025-03-04	2025-03-05	3,400	$30.73	$104.5K	24,452	SEC↗
CHILDS JOHN W	Director	P Buy	2025-03-04	2025-03-05	3,400	$30.73	$104.5K	76,570	SEC↗
CHILDS JOHN W	Director	P Buy	2025-03-04	2025-03-05	900	$30.73	$27.7K	25,291	SEC↗
Coric Vlad	Chief Executive Officer	M Exercise deriv	2025-01-05	2025-01-07	14,250	—	$0	42,750	SEC↗
Coric Vlad	Chief Executive Officer	A Award deriv	2025-01-05	2025-01-07	57,000	—	$0	57,000	SEC↗
Coric Vlad	Chief Executive Officer	A Award deriv	2025-01-05	2025-01-07	343,000	—	$0	343,000	SEC↗
Buten Matthew	Chief Financial Officer	A Award deriv	2025-01-05	2025-01-07	104,000	—	$0	104,000	SEC↗
Buten Matthew	Chief Financial Officer	M Exercise deriv	2025-01-05	2025-01-07	4,250	—	$0	12,750	SEC↗
Buten Matthew	Chief Financial Officer	A Award deriv	2025-01-05	2025-01-07	17,000	—	$0	17,000	SEC↗
Clark George C.	VP, Chief Accounting Officer	A Award deriv	2025-01-05	2025-01-07	30,000	—	$0	30,000	SEC↗
Clark George C.	VP, Chief Accounting Officer	A Award deriv	2025-01-05	2025-01-07	10,000	—	$0	10,000	SEC↗
Clark George C.	VP, Chief Accounting Officer	M Exercise deriv	2025-01-05	2025-01-07	2,500	—	$0	7,500	SEC↗
Gentile Kimberly	SVP, Clinical Operations	A Award deriv	2025-01-05	2025-01-07	15,000	—	$0	15,000	SEC↗
Gentile Kimberly	SVP, Clinical Operations	A Award deriv	2025-01-05	2025-01-07	91,000	—	$0	91,000	SEC↗
Gentile Kimberly	SVP, Clinical Operations	M Exercise deriv	2025-01-05	2025-01-07	3,750	—	$0	11,250	SEC↗
Car Bruce	Chief Scientific Officer	M Exercise deriv	2025-01-05	2025-01-07	4,750	—	$0	14,250	SEC↗
Car Bruce	Chief Scientific Officer	A Award deriv	2025-01-05	2025-01-07	19,000	—	$0	19,000	SEC↗
Car Bruce	Chief Scientific Officer	A Award deriv	2025-01-05	2025-01-07	112,000	—	$0	112,000	SEC↗
Coric Vlad	Chief Executive Officer	M Exercise	2025-01-05	2025-01-07	14,250	—	$0	1,803,409	SEC↗
Coric Vlad	Chief Executive Officer	F Tax w/h	2025-01-05	2025-01-07	6,805	$38.64	$262.9K	1,796,604	SEC↗
Buten Matthew	Chief Financial Officer	M Exercise	2025-01-05	2025-01-07	4,250	—	$0	196,013	SEC↗
Buten Matthew	Chief Financial Officer	F Tax w/h	2025-01-05	2025-01-07	2,561	$38.64	$99.0K	193,452	SEC↗
Clark George C.	VP, Chief Accounting Officer	M Exercise	2025-01-05	2025-01-07	2,500	—	$0	66,168	SEC↗
Clark George C.	VP, Chief Accounting Officer	F Tax w/h	2025-01-05	2025-01-07	1,117	$38.64	$43.2K	65,051	SEC↗
Gentile Kimberly	SVP, Clinical Operations	M Exercise	2025-01-05	2025-01-07	3,750	—	$0	99,719	SEC↗
Gentile Kimberly	SVP, Clinical Operations	F Tax w/h	2025-01-05	2025-01-07	1,956	$38.64	$75.6K	97,763	SEC↗
Car Bruce	Chief Scientific Officer	M Exercise	2025-01-05	2025-01-07	4,750	—	$0	7,133	SEC↗
Car Bruce	Chief Scientific Officer	F Tax w/h	2025-01-05	2025-01-07	2,331	$38.64	$90.1K	4,802	SEC↗
CHILDS JOHN W	Director	P Buy	2024-12-30	2024-12-31	29,000	$35.94	$1.04M	2,368,741	SEC↗
Coric Vlad	Chief Executive Officer	P Buy	2024-10-02	2024-10-03	21,052	$47.50	$1000.0K	861,942	SEC↗
CHILDS JOHN W	Director	P Buy	2024-10-02	2024-10-03	21,052	$47.50	$1000.0K	21,052	SEC↗
Bailey Gregory	Director	P Buy	2024-09-24	2024-09-25	5,000	$44.19	$220.9K	1,620,071	SEC↗
CHILDS JOHN W	Director	P Buy	2024-07-18	2024-07-19	28,400	$35.67	$1.01M	2,339,741	SEC↗
Car Bruce	Chief Scientific Officer	P Buy	2024-06-17	2024-06-20	30,000	$33.58	$1.01M	30,000	SEC↗
CHILDS JOHN W	Director	P Buy	2024-05-30	2024-05-31	28,000	$35.58	$996.2K	2,311,341	SEC↗
CHILDS JOHN W	Director	P Buy	2024-05-13	2024-05-14	28,500	$35.17	$1.00M	2,283,341	SEC↗
Bailey Gregory	Director	P Buy	2024-05-13	2024-05-15	15,000	$34.19	$512.8K	1,615,071	SEC↗
Bailey Gregory	Director	A Award deriv	2024-04-30	2024-05-02	16,592	—	$0	16,592	SEC↗
CHILDS JOHN W	Director	A Award deriv	2024-04-30	2024-05-02	16,592	—	$0	16,592	SEC↗
Antonijevic Irina	Director	A Award deriv	2024-04-30	2024-05-02	16,592	—	$0	16,592	SEC↗
HUGIN ROBERT J	Director	A Award deriv	2024-04-30	2024-05-02	16,592	—	$0	16,592	SEC↗
GREGORY JULIA P	Director	A Award deriv	2024-04-30	2024-05-02	16,592	—	$0	16,592	SEC↗
Heffernan Michael Thomas	Director	A Award deriv	2024-04-30	2024-05-02	16,592	—	$0	16,592	SEC↗
Mehta Kishan	Director	A Award deriv	2024-04-30	2024-05-02	16,592	—	$0	16,592	SEC↗
Bailey Gregory	Director	P Buy	2024-04-24	2024-04-25	25,503	$39.18	$999.2K	1,600,071	SEC↗
CHILDS JOHN W	Director	P Buy	2024-04-22	2025-03-05	73,170	$41.00	$3.00M	73,170	SEC↗
Coric Vlad	Chief Executive Officer	P Buy	2024-04-22	2024-04-23	121,951	$41.00	$5.00M	1,788,417	SEC↗
CHILDS JOHN W	Director	P Buy	2024-04-22	2024-04-23	24,391	$41.00	$1.00M	24,391	SEC↗
CHILDS JOHN W	Director	P Buy	2024-04-22	2024-04-23	73,170	$41.00	$3.00M	2,254,841	SEC↗
CHILDS JOHN W	Director	P Buy	2024-04-22	2024-04-23	97,560	$41.00	$4.00M	4,096,512	SEC↗
Bailey Gregory	Director	P Buy	2024-04-22	2024-04-23	48,780	$41.00	$2.00M	1,574,568	SEC↗
Coric Vlad	Chief Executive Officer	A Award	2024-04-05	2024-04-05	231	—	$0	840,890	SEC↗
Coric Vlad	Chief Executive Officer	A Award	2024-04-05	2024-04-05	232	—	$0	1,666,466	SEC↗
Coric Vlad	Chief Executive Officer	A Award	2024-04-05	2024-04-05	231	—	$0	407,213	SEC↗
CHILDS JOHN W	Director	A Award	2024-04-05	2024-04-05	2,091	—	$0	2,181,671	SEC↗
Coric Vlad	Chief Executive Officer	A Award	2024-03-08	2024-03-08	2,155	—	$0	840,659	SEC↗
Coric Vlad	Chief Executive Officer	A Award	2024-03-08	2024-03-08	2,155	—	$0	406,982	SEC↗
Coric Vlad	Chief Executive Officer	A Award	2024-03-08	2024-03-08	2,162	—	$0	1,666,234	SEC↗
CHILDS JOHN W	Director	A Award	2024-03-08	2024-03-08	19,412	—	$0	2,179,580	SEC↗
Coric Vlad	Chief Executive Officer	A Award	2024-01-08	2024-01-10	5,384	—	$0	404,827	SEC↗
Coric Vlad	Chief Executive Officer	A Award	2024-01-08	2024-01-10	5,384	—	$0	838,504	SEC↗
Coric Vlad	Chief Executive Officer	A Award	2024-01-08	2024-01-10	5,400	—	$0	1,662,431	SEC↗
CHILDS JOHN W	Director	J Other	2024-01-08	2024-01-10	48,505	—	$0	2,160,168	SEC↗
Coric Vlad	Chief Executive Officer	A Award deriv	2024-01-02	2024-01-04	275,000	—	$0	275,000	SEC↗
Buten Matthew	Chief Financial Officer	A Award deriv	2024-01-02	2024-01-04	96,250	—	$0	96,250	SEC↗
Gentile Kimberly	SVP, Clinical Operations	A Award deriv	2024-01-02	2024-01-04	96,250	—	$0	96,250	SEC↗
Car Bruce	Chief Scientific Officer	A Award deriv	2024-01-02	2024-01-04	96,250	—	$0	96,250	SEC↗
Clark George C.	VP, Chief Accounting Officer	A Award deriv	2024-01-02	2024-01-04	27,500	—	$0	27,500	SEC↗
Antonijevic Irina	Director	M Exercise deriv	2023-12-29	2023-12-29	11,000	—	$0	114,000	SEC↗
Antonijevic Irina	Director	S Sale	2023-12-29	2023-12-29	11,000	$41.79	$459.7K	2,535	SEC↗
Antonijevic Irina	Director	M Exercise	2023-12-29	2023-12-29	11,000	—	$0	13,535	SEC↗
Car Bruce	Chief Scientific Officer	A Award deriv	2023-11-02	2023-11-06	78,750	—	$0	78,750	SEC↗
Gentile Kimberly	SVP, Clinical Operations	A Award deriv	2023-11-02	2023-11-06	78,750	—	$0	78,750	SEC↗
Clark George C.	VP, Chief Accounting Officer	A Award deriv	2023-11-02	2023-11-06	22,500	—	$0	22,500	SEC↗
Coric Vlad	Chief Executive Officer	A Award deriv	2023-11-02	2023-11-06	225,000	—	$0	225,000	SEC↗
Buten Matthew	Chief Financial Officer	A Award deriv	2023-11-02	2023-11-06	78,750	—	$0	78,750	SEC↗
Buten Matthew	Chief Financial Officer	P Buy	2023-10-05	2023-10-06	22,727	$22.00	$500.0K	189,380	SEC↗
Coric Vlad	Chief Executive Officer	P Buy	2023-10-05	2023-10-10	113,637	$22.00	$2.50M	1,657,031	SEC↗
Coric Vlad	Chief Executive Officer	P Buy	2023-10-05	2023-10-10	340,908	$22.00	$7.50M	833,120	SEC↗
CHILDS JOHN W	Director	P Buy	2023-10-05	2023-10-10	136,545	$22.00	$3.00M	2,111,663	SEC↗
CHILDS JOHN W	Director	P Buy	2023-10-05	2023-10-10	318,000	$22.00	$7.00M	3,998,952	SEC↗
Bailey Gregory	Director	P Buy	2023-10-04	2023-10-06	17,817	$22.57	$402.1K	1,525,788	SEC↗
CHILDS JOHN W	Director	P Buy	2023-08-30	2023-08-31	50,000	$18.44	$922.0K	1,975,118	SEC↗
CHILDS JOHN W	Director	P Buy	2023-08-04	2023-08-07	100,000	$19.78	$1.98M	1,925,118	SEC↗
HUGIN ROBERT J	Director	A Award deriv	2023-05-02	2023-05-04	52,906	—	$0	52,906	SEC↗
Heffernan Michael Thomas	Director	A Award deriv	2023-05-02	2023-05-04	52,906	—	$0	52,906	SEC↗
CHILDS JOHN W	Director	A Award deriv	2023-05-02	2023-05-04	52,906	—	$0	52,906	SEC↗
Antonijevic Irina	Director	A Award deriv	2023-05-02	2023-05-04	52,906	—	$0	52,906	SEC↗
GREGORY JULIA P	Director	A Award deriv	2023-05-02	2023-05-04	52,906	—	$0	52,906	SEC↗
Mehta Kishan	Director	A Award deriv	2023-05-02	2023-05-04	52,906	—	$0	52,906	SEC↗
Bailey Gregory	Director	A Award deriv	2023-05-02	2023-05-04	52,906	—	$0	52,906	SEC↗
Coric Vlad	Chief Executive Officer	P Buy	2022-10-31	2022-11-01	25,800	$15.97	$412.0K	1,543,394	SEC↗
Coric Vlad	Chief Executive Officer	P Buy	2022-10-28	2022-10-31	100,000	$14.82	$1.48M	109,565	SEC↗
Coric Vlad	Chief Executive Officer	P Buy	2022-10-28	2022-10-31	41,930	$14.87	$623.5K	1,517,594	SEC↗
CHILDS JOHN W	Director	P Buy	2022-10-25	2023-03-22	1,328,867	$10.50	$13.95M	1,825,118	SEC↗
CHILDS JOHN W	Director	P Buy	2022-10-25	2023-03-22	2,380,952	$10.50	$25.00M	3,680,952	SEC↗
Coric Vlad	Chief Executive Officer	P Buy	2022-10-25	2022-10-26	853,380	$10.50	$8.96M	1,475,664	SEC↗
Buten Matthew	Chief Financial Officer	P Buy	2022-10-25	2022-10-26	142,857	$10.50	$1.50M	166,653	SEC↗
CHILDS JOHN W	Director	P Buy	2022-10-25	2022-10-26	3,900,000	$10.50	$40.95M	5,691,251	SEC↗
Bailey Gregory	Director	P Buy	2022-10-25	2022-10-26	200,000	$10.50	$2.10M	1,507,971	SEC↗
GREGORY JULIA P	Director	P Buy	2022-10-25	2022-10-26	9,523	$10.50	$100.0K	25,665	SEC↗
CHILDS JOHN W	Director	P Buy	2022-10-05	2022-10-05	32,841	$9.70	$318.6K	1,791,251	SEC↗
CHILDS JOHN W	Director	P Buy	2022-10-05	2022-10-05	241,300	$8.88	$2.14M	1,758,410	SEC↗
Coric Vlad	Chief Executive Officer	P Buy	2022-10-05	2022-10-06	2,100	$12.35	$25.9K	399,443	SEC↗
Coric Vlad	Chief Executive Officer	P Buy	2022-10-05	2022-10-06	54,329	$11.83	$642.7K	492,212	SEC↗
Coric Vlad	Chief Executive Officer	P Buy	2022-10-05	2022-10-06	73,331	$8.82	$646.8K	322,461	SEC↗
Coric Vlad	Chief Executive Officer	P Buy	2022-10-05	2022-10-06	73,005	$8.82	$643.9K	229,755	SEC↗
Coric Vlad	Chief Executive Officer	P Buy	2022-10-05	2022-10-06	34,515	$9.90	$341.7K	356,976	SEC↗
Coric Vlad	Chief Executive Officer	P Buy	2022-10-05	2022-10-06	52,523	$11.79	$619.2K	397,343	SEC↗
Coric Vlad	Chief Executive Officer	P Buy	2022-10-05	2022-10-06	80,606	$10.82	$872.2K	344,820	SEC↗
Coric Vlad	Chief Executive Officer	P Buy	2022-10-05	2022-10-06	80,907	$10.83	$876.2K	437,883	SEC↗
Coric Vlad	Chief Executive Officer	P Buy	2022-10-05	2022-10-06	34,459	$9.89	$340.8K	264,214	SEC↗
Gentile Kimberly	SVP, Clinical Operations	D To issuer deriv	2022-10-03	2022-10-03	25,000	—	$0	0	SEC↗
Gentile Kimberly	SVP, Clinical Operations	D To issuer deriv	2022-10-03	2022-10-03	3,750	—	$0	0	SEC↗
Gentile Kimberly	SVP, Clinical Operations	D To issuer deriv	2022-10-03	2022-10-03	775	—	$0	0	SEC↗
Gentile Kimberly	SVP, Clinical Operations	D To issuer deriv	2022-10-03	2022-10-03	25,225	—	$0	0	SEC↗
Gentile Kimberly	SVP, Clinical Operations	D To issuer deriv	2022-10-03	2022-10-03	2,398	—	$0	0	SEC↗
Gentile Kimberly	SVP, Clinical Operations	D To issuer deriv	2022-10-03	2022-10-03	27,602	—	$0	0	SEC↗
Gentile Kimberly	SVP, Clinical Operations	D To issuer deriv	2022-10-03	2022-10-03	28,000	—	$0	0	SEC↗
Gentile Kimberly	SVP, Clinical Operations	D To issuer deriv	2022-10-03	2022-10-03	6,000	—	$0	0	SEC↗
Gentile Kimberly	SVP, Clinical Operations	D To issuer deriv	2022-10-03	2022-10-03	61,916	—	$0	0	SEC↗
Gentile Kimberly	SVP, Clinical Operations	D To issuer deriv	2022-10-03	2022-10-03	3,084	—	$0	0	SEC↗
Gentile Kimberly	SVP, Clinical Operations	D To issuer deriv	2022-10-03	2022-10-03	590	—	$0	0	SEC↗
Gentile Kimberly	SVP, Clinical Operations	D To issuer deriv	2022-10-03	2022-10-03	41,432	—	$0	0	SEC↗
Gentile Kimberly	SVP, Clinical Operations	D To issuer deriv	2022-10-03	2022-10-03	9,000	—	$0	0	SEC↗
Gentile Kimberly	SVP, Clinical Operations	D To issuer deriv	2022-10-03	2022-10-03	7,500	—	$0	0	SEC↗
Gentile Kimberly	SVP, Clinical Operations	D To issuer deriv	2022-10-03	2022-10-03	13,000	—	$0	0	SEC↗
Conway Charles	Chief Scientific Officer	D To issuer deriv	2022-10-03	2022-10-03	7,500	—	$0	0	SEC↗
Conway Charles	Chief Scientific Officer	D To issuer deriv	2022-10-03	2022-10-03	3,000	—	$0	0	SEC↗
Conway Charles	Chief Scientific Officer	D To issuer deriv	2022-10-03	2022-10-03	775	—	$0	0	SEC↗
Conway Charles	Chief Scientific Officer	D To issuer deriv	2022-10-03	2022-10-03	25,225	—	$0	0	SEC↗
Conway Charles	Chief Scientific Officer	D To issuer deriv	2022-10-03	2022-10-03	2,398	—	$0	0	SEC↗
Conway Charles	Chief Scientific Officer	D To issuer deriv	2022-10-03	2022-10-03	27,602	—	$0	0	SEC↗
Conway Charles	Chief Scientific Officer	D To issuer deriv	2022-10-03	2022-10-03	25,000	—	$0	0	SEC↗
Conway Charles	Chief Scientific Officer	D To issuer deriv	2022-10-03	2022-10-03	6,000	—	$0	0	SEC↗
Conway Charles	Chief Scientific Officer	D To issuer deriv	2022-10-03	2022-10-03	41,432	—	$0	0	SEC↗
Conway Charles	Chief Scientific Officer	D To issuer deriv	2022-10-03	2022-10-03	5,000	—	$0	0	SEC↗
Conway Charles	Chief Scientific Officer	D To issuer deriv	2022-10-03	2022-10-03	54,000	—	$0	0	SEC↗
Conway Charles	Chief Scientific Officer	D To issuer deriv	2022-10-03	2022-10-03	61,916	—	$0	0	SEC↗
Conway Charles	Chief Scientific Officer	D To issuer deriv	2022-10-03	2022-10-03	3,084	—	$0	0	SEC↗
Conway Charles	Chief Scientific Officer	D To issuer deriv	2022-10-03	2022-10-03	295	—	$0	0	SEC↗
Conway Charles	Chief Scientific Officer	D To issuer deriv	2022-10-03	2022-10-03	11,500	—	$0	0	SEC↗
Stock Elyse	Chief Medical Officer	D To issuer deriv	2022-10-03	2022-10-03	7,500	—	$0	0	SEC↗
Stock Elyse	Chief Medical Officer	D To issuer deriv	2022-10-03	2022-10-03	9,750	—	$0	0	SEC↗
Stock Elyse	Chief Medical Officer	D To issuer deriv	2022-10-03	2022-10-03	3,375	—	$0	0	SEC↗
Stock Elyse	Chief Medical Officer	D To issuer deriv	2022-10-03	2022-10-03	3,000	—	$0	0	SEC↗
Stock Elyse	Chief Medical Officer	D To issuer deriv	2022-10-03	2022-10-03	2,500	—	$0	0	SEC↗
Stock Elyse	Chief Medical Officer	D To issuer deriv	2022-10-03	2022-10-03	45,666	—	$0	0	SEC↗
Stock Elyse	Chief Medical Officer	D To issuer deriv	2022-10-03	2022-10-03	2,548	—	$0	0	SEC↗
Stock Elyse	Chief Medical Officer	D To issuer deriv	2022-10-03	2022-10-03	8,452	—	$0	0	SEC↗
Stock Elyse	Chief Medical Officer	D To issuer deriv	2022-10-03	2022-10-03	7,500	—	$0	0	SEC↗
Stock Elyse	Chief Medical Officer	D To issuer deriv	2022-10-03	2022-10-03	10,000	—	$0	0	SEC↗
Stock Elyse	Chief Medical Officer	D To issuer deriv	2022-10-03	2022-10-03	10,358	—	$0	0	SEC↗
Stock Elyse	Chief Medical Officer	D To issuer deriv	2022-10-03	2022-10-03	1,180	—	$0	0	SEC↗
Stock Elyse	Chief Medical Officer	D To issuer deriv	2022-10-03	2022-10-03	3,084	—	$0	0	SEC↗
Stock Elyse	Chief Medical Officer	D To issuer deriv	2022-10-03	2022-10-03	6,000	—	$0	0	SEC↗
Stock Elyse	Chief Medical Officer	D To issuer deriv	2022-10-03	2022-10-03	25,000	—	$0	0	SEC↗
Stock Elyse	Chief Medical Officer	D To issuer deriv	2022-10-03	2022-10-03	27,602	—	$0	0	SEC↗
Stock Elyse	Chief Medical Officer	D To issuer deriv	2022-10-03	2022-10-03	2,398	—	$0	0	SEC↗
Stock Elyse	Chief Medical Officer	D To issuer deriv	2022-10-03	2022-10-03	25,225	—	$0	0	SEC↗
Stock Elyse	Chief Medical Officer	D To issuer deriv	2022-10-03	2022-10-03	775	—	$0	0	SEC↗
Stock Elyse	Chief Medical Officer	D To issuer deriv	2022-10-03	2022-10-03	938	—	$0	0	SEC↗
Clark George C.	VP, Chief Accounting Officer	D To issuer deriv	2022-10-03	2022-10-03	9,225	—	$0	0	SEC↗
Clark George C.	VP, Chief Accounting Officer	D To issuer deriv	2022-10-03	2022-10-03	960	—	$0	0	SEC↗
Clark George C.	VP, Chief Accounting Officer	D To issuer deriv	2022-10-03	2022-10-03	1,915	—	$0	0	SEC↗
Clark George C.	VP, Chief Accounting Officer	D To issuer deriv	2022-10-03	2022-10-03	2,250	—	$0	0	SEC↗
Clark George C.	VP, Chief Accounting Officer	D To issuer deriv	2022-10-03	2022-10-03	4,602	—	$0	0	SEC↗
Clark George C.	VP, Chief Accounting Officer	D To issuer deriv	2022-10-03	2022-10-03	2,398	—	$0	0	SEC↗
Clark George C.	VP, Chief Accounting Officer	D To issuer deriv	2022-10-03	2022-10-03	10,000	—	$0	0	SEC↗
Clark George C.	VP, Chief Accounting Officer	D To issuer deriv	2022-10-03	2022-10-03	1,250	—	$0	0	SEC↗
Clark George C.	VP, Chief Accounting Officer	D To issuer deriv	2022-10-03	2022-10-03	775	—	$0	0	SEC↗
Clark George C.	VP, Chief Accounting Officer	D To issuer deriv	2022-10-03	2022-10-03	1,000	—	$0	0	SEC↗
Clark George C.	VP, Chief Accounting Officer	D To issuer deriv	2022-10-03	2022-10-03	1,750	—	$0	0	SEC↗
Clark George C.	VP, Chief Accounting Officer	D To issuer deriv	2022-10-03	2022-10-03	15,000	—	$0	0	SEC↗
Clark George C.	VP, Chief Accounting Officer	D To issuer deriv	2022-10-03	2022-10-03	1,000	—	$0	0	SEC↗
Clark George C.	VP, Chief Accounting Officer	D To issuer deriv	2022-10-03	2022-10-03	3,000	—	$0	0	SEC↗
Bailey Gregory	Director	D To issuer deriv	2022-10-03	2022-10-03	8,239	—	$0	0	SEC↗
Bailey Gregory	Director	D To issuer deriv	2022-10-03	2022-10-03	11,996	—	$0	0	SEC↗
Bailey Gregory	Director	D To issuer deriv	2022-10-03	2022-10-03	18,000	—	$0	0	SEC↗
Bailey Gregory	Director	D To issuer deriv	2022-10-03	2022-10-03	18,000	—	$0	0	SEC↗
Antonijevic Irina	Director	D To issuer deriv	2022-10-03	2022-10-03	5,070	—	$0	0	SEC↗
Engelhart James	Strategic Advisor	D To issuer deriv	2022-10-03	2022-10-03	29,500	—	$0	0	SEC↗
Engelhart James	Strategic Advisor	D To issuer deriv	2022-10-03	2022-10-03	27,602	—	$0	0	SEC↗
Engelhart James	Strategic Advisor	D To issuer deriv	2022-10-03	2022-10-03	2,398	—	$0	0	SEC↗
Engelhart James	Strategic Advisor	D To issuer deriv	2022-10-03	2022-10-03	25,225	—	$0	0	SEC↗
Engelhart James	Strategic Advisor	D To issuer deriv	2022-10-03	2022-10-03	775	—	$0	0	SEC↗
Engelhart James	Strategic Advisor	D To issuer deriv	2022-10-03	2022-10-03	71,916	—	$0	0	SEC↗
Engelhart James	Strategic Advisor	D To issuer deriv	2022-10-03	2022-10-03	3,084	—	$0	0	SEC↗
Engelhart James	Strategic Advisor	D To issuer deriv	2022-10-03	2022-10-03	3,700	—	$0	0	SEC↗
Engelhart James	Strategic Advisor	D To issuer deriv	2022-10-03	2022-10-03	59,024	—	$0	0	SEC↗
Engelhart James	Strategic Advisor	D To issuer deriv	2022-10-03	2022-10-03	40,000	—	$0	0	SEC↗
Engelhart James	Strategic Advisor	D To issuer deriv	2022-10-03	2022-10-03	83,792	—	$0	0	SEC↗
Engelhart James	Strategic Advisor	D To issuer deriv	2022-10-03	2022-10-03	9,750	—	$0	0	SEC↗
Engelhart James	Strategic Advisor	D To issuer deriv	2022-10-03	2022-10-03	7,500	—	$0	0	SEC↗
Engelhart James	Strategic Advisor	D To issuer deriv	2022-10-03	2022-10-03	19,240	—	$0	0	SEC↗
Tilton John	Chief Commercial Officer	D To issuer deriv	2022-10-03	2022-10-03	37,292	—	$0	0	SEC↗
Tilton John	Chief Commercial Officer	D To issuer deriv	2022-10-03	2022-10-03	19,240	—	$0	0	SEC↗
Tilton John	Chief Commercial Officer	D To issuer deriv	2022-10-03	2022-10-03	2,500	—	$0	0	SEC↗
Tilton John	Chief Commercial Officer	D To issuer deriv	2022-10-03	2022-10-03	4,000	—	$0	0	SEC↗
Tilton John	Chief Commercial Officer	D To issuer deriv	2022-10-03	2022-10-03	7,602	—	$0	0	SEC↗
Tilton John	Chief Commercial Officer	D To issuer deriv	2022-10-03	2022-10-03	10,000	—	$0	0	SEC↗
Tilton John	Chief Commercial Officer	D To issuer deriv	2022-10-03	2022-10-03	26,916	—	$0	0	SEC↗
Tilton John	Chief Commercial Officer	D To issuer deriv	2022-10-03	2022-10-03	3,084	—	$0	0	SEC↗
Tilton John	Chief Commercial Officer	D To issuer deriv	2022-10-03	2022-10-03	1,250	—	$0	0	SEC↗
Tilton John	Chief Commercial Officer	D To issuer deriv	2022-10-03	2022-10-03	775	—	$0	0	SEC↗
Tilton John	Chief Commercial Officer	D To issuer deriv	2022-10-03	2022-10-03	6,225	—	$0	0	SEC↗
Tilton John	Chief Commercial Officer	D To issuer deriv	2022-10-03	2022-10-03	2,398	—	$0	0	SEC↗
Tilton John	Chief Commercial Officer	D To issuer deriv	2022-10-03	2022-10-03	2,625	—	$0	0	SEC↗
Tilton John	Chief Commercial Officer	D To issuer deriv	2022-10-03	2022-10-03	2,500	—	$0	0	SEC↗
GREGORY JULIA P	Director	D To issuer deriv	2022-10-03	2022-10-03	8,239	—	$0	0	SEC↗
GREGORY JULIA P	Director	D To issuer deriv	2022-10-03	2022-10-03	11,996	—	$0	0	SEC↗
GREGORY JULIA P	Director	D To issuer deriv	2022-10-03	2022-10-03	18,000	—	$0	0	SEC↗
GREGORY JULIA P	Director	D To issuer deriv	2022-10-03	2022-10-03	18,000	—	$0	0	SEC↗
Mehta Kishan	Director	D To issuer deriv	2022-10-03	2022-10-03	8,239	—	$0	0	SEC↗
Mehta Kishan	Director	D To issuer deriv	2022-10-03	2022-10-03	13,004	—	$0	0	SEC↗
Mehta Kishan	Director	D To issuer deriv	2022-10-03	2022-10-03	15,000	—	$0	0	SEC↗
Mehta Kishan	Director	D To issuer deriv	2022-10-03	2022-10-03	20,000	—	$0	0	SEC↗
Mehta Kishan	Director	D To issuer deriv	2022-10-03	2022-10-03	1,875	—	$0	0	SEC↗
Buten Matthew	Chief Financial Officer	D To issuer deriv	2022-10-03	2022-10-03	37,500	—	$0	0	SEC↗
Buten Matthew	Chief Financial Officer	D To issuer deriv	2022-10-03	2022-10-03	3,100	—	$0	0	SEC↗
Buten Matthew	Chief Financial Officer	D To issuer deriv	2022-10-03	2022-10-03	22,900	—	$0	0	SEC↗
Heffernan Michael Thomas	Director	D To issuer deriv	2022-10-03	2022-10-03	11,996	—	$0	0	SEC↗
Heffernan Michael Thomas	Director	D To issuer deriv	2022-10-03	2022-10-03	8,239	—	$0	0	SEC↗
Heffernan Michael Thomas	Director	D To issuer deriv	2022-10-03	2022-10-03	3,320	—	$0	0	SEC↗
Heffernan Michael Thomas	Director	D To issuer deriv	2022-10-03	2022-10-03	26,200	—	$0	0	SEC↗
HUGIN ROBERT J	Director	D To issuer deriv	2022-10-03	2022-10-03	11,996	—	$0	0	SEC↗
HUGIN ROBERT J	Director	D To issuer deriv	2022-10-03	2022-10-03	18,948	—	$0	0	SEC↗
HUGIN ROBERT J	Director	D To issuer deriv	2022-10-03	2022-10-03	3,417	—	$0	0	SEC↗
HUGIN ROBERT J	Director	D To issuer deriv	2022-10-03	2022-10-03	8,239	—	$0	0	SEC↗
JONES WILLIAM A JR	CCO-Migraine & Common Diseas	D To issuer deriv	2022-10-03	2022-10-03	29,225	—	$0	0	SEC↗
JONES WILLIAM A JR	CCO-Migraine & Common Diseas	D To issuer deriv	2022-10-03	2022-10-03	775	—	$0	0	SEC↗
JONES WILLIAM A JR	CCO-Migraine & Common Diseas	D To issuer deriv	2022-10-03	2022-10-03	3,000	—	$0	0	SEC↗
JONES WILLIAM A JR	CCO-Migraine & Common Diseas	D To issuer deriv	2022-10-03	2022-10-03	10,000	—	$0	0	SEC↗
JONES WILLIAM A JR	CCO-Migraine & Common Diseas	D To issuer deriv	2022-10-03	2022-10-03	11,250	—	$0	0	SEC↗
JONES WILLIAM A JR	CCO-Migraine & Common Diseas	D To issuer deriv	2022-10-03	2022-10-03	44,087	—	$0	0	SEC↗
JONES WILLIAM A JR	CCO-Migraine & Common Diseas	D To issuer deriv	2022-10-03	2022-10-03	2,398	—	$0	0	SEC↗
JONES WILLIAM A JR	CCO-Migraine & Common Diseas	D To issuer deriv	2022-10-03	2022-10-03	37,602	—	$0	0	SEC↗
JONES WILLIAM A JR	CCO-Migraine & Common Diseas	D To issuer deriv	2022-10-03	2022-10-03	1,742	—	$0	0	SEC↗
JONES WILLIAM A JR	CCO-Migraine & Common Diseas	D To issuer deriv	2022-10-03	2022-10-03	5,913	—	$0	0	SEC↗
JONES WILLIAM A JR	CCO-Migraine & Common Diseas	D To issuer deriv	2022-10-03	2022-10-03	28,258	—	$0	0	SEC↗
Coric Vlad	Chief Executive Officer	D To issuer deriv	2022-10-03	2022-10-03	196,916	—	$0	0	SEC↗
Coric Vlad	Chief Executive Officer	D To issuer deriv	2022-10-03	2022-10-03	250,000	—	$0	0	SEC↗
Coric Vlad	Chief Executive Officer	D To issuer deriv	2022-10-03	2022-10-03	75,000	—	$0	0	SEC↗
Coric Vlad	Chief Executive Officer	D To issuer deriv	2022-10-03	2022-10-03	100,000	—	$0	0	SEC↗
Coric Vlad	Chief Executive Officer	D To issuer deriv	2022-10-03	2022-10-03	50,000	—	$0	0	SEC↗
Coric Vlad	Chief Executive Officer	D To issuer deriv	2022-10-03	2022-10-03	40,000	—	$0	0	SEC↗
Coric Vlad	Chief Executive Officer	D To issuer deriv	2022-10-03	2022-10-03	180,760	—	$0	0	SEC↗
Coric Vlad	Chief Executive Officer	D To issuer deriv	2022-10-03	2022-10-03	19,240	—	$0	0	SEC↗
Coric Vlad	Chief Executive Officer	D To issuer deriv	2022-10-03	2022-10-03	3,084	—	$0	0	SEC↗
Coric Vlad	Chief Executive Officer	D To issuer deriv	2022-10-03	2022-10-03	87,500	—	$0	0	SEC↗
Coric Vlad	Chief Executive Officer	D To issuer deriv	2022-10-03	2022-10-03	97,602	—	$0	0	SEC↗
Coric Vlad	Chief Executive Officer	D To issuer deriv	2022-10-03	2022-10-03	2,398	—	$0	0	SEC↗
Coric Vlad	Chief Executive Officer	D To issuer deriv	2022-10-03	2022-10-03	69,225	—	$0	0	SEC↗
Coric Vlad	Chief Executive Officer	D To issuer deriv	2022-10-03	2022-10-03	775	—	$0	0	SEC↗
Coric Vlad	Chief Executive Officer	D To issuer deriv	2022-10-03	2022-10-03	10,950	—	$0	0	SEC↗